A case of infliximab-induced lupus in a patient with ankylosing spondylitis: is it safe switch to another anti-TNF-α agent?
about
Autoimmunogenicity during anti-TNF therapy in patients with psoriasis and psoriatic arthritisIs the risk of tumour necrosis factor inhibitor-induced lupus or lupus-like syndrome the same with monoclonal antibodies and soluble receptor? A case/non-case study in a nationwide pharmacovigilance database.Anti-tumor Necrosis Factor Alpha (Infliximab) Attenuates Apoptosis, Oxidative Stress, and Calcium Ion Entry Through Modulation of Cation Channels in Neutrophils of Patients with Ankylosing Spondylitis.Management Decisions for Rheumatoid Arthritis After Tumor Necrosis Factor Alpha Antagonist-Induced Lupus-Like Syndrome
P2860
A case of infliximab-induced lupus in a patient with ankylosing spondylitis: is it safe switch to another anti-TNF-α agent?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
A case of infliximab-induced l ...... h to another anti-TNF-α agent?
@en
type
label
A case of infliximab-induced l ...... h to another anti-TNF-α agent?
@en
prefLabel
A case of infliximab-induced l ...... h to another anti-TNF-α agent?
@en
P2093
P2860
P1476
A case of infliximab-induced l ...... h to another anti-TNF-α agent?
@en
P2093
Armando Malcata
Cátia Duarte
José António Pereira da Silva
João Rovisco
Mariana Galante Santiago
P2860
P304
P356
10.1007/S10067-013-2361-9
P577
2013-08-17T00:00:00Z